Dr. Litz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1355 River Bend Dr
Dallas, TX 75247Phone+1 214-237-1638
Summary
- Before joining ProPath, Dr. Litz was associate professor and co-director of the Special Hematology Laboratory at the University of Minnesota where he acquired extensive experience in the morphologic diagnosis of hematologic abnormalities. For his research activities in chronic myeloid leukemia, he became the first pathologist named Scholar of the American Society of Hematology (1991). In 2004 he served as the president of the medical staff of St. Paul University Hospital in Dallas, TX. He is currently director of hematopathology and pathologist at ProPath and clinical professor at the University of Texas Southwestern Medical School.
Education & Training
- University of MinnesotaFellowship, Hematopathology, 1988 - 1990
- University of MinnesotaResidency, Pathology-Anatomic and Clinical, 1984 - 1988
- Virginia Commonwealth University School of MedicineClass of 1984
- GeorgetownBS, Chemistry, Magna Cum Laude, 1976 - 1980
Certifications & Licensure
- AZ State Medical License 2012 - 2026
- MI State Medical License 2016 - 2026
- RI State Medical License 2024 - 2026
- TX State Medical License 1997 - 2026
- AR State Medical License 2016 - 2025
- GA State Medical License 2018 - 2025
- IN State Medical License 2019 - 2025
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
- Join now to see all
Awards, Honors, & Recognition
- Scholar American Society of Hematology, 1992-1994
- Alpha Omega Alpha 1983
- Phi Beta Kappa 1979
Publications & Presentations
PubMed
- 234 citationsPilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients.John Nemunaitis, Casey Cunningham, Neil Senzer, Joseph A. Kuhn, Jennifer Cramm
Cancer Gene Therapy. 2003-10-01 - 16 citationsAberrant methylation of the major breakpoint cluster region in chronic myeloid leukemiaCraig E. Litz, Jeffery A. Vos, Cedith M. Copenhaver
Blood. 1996-09-15 - 11 citationsAberrant DNA methylation of genomic regions translocated in myeloid malignancies.Craig E. Litz, Joan Etzell
Leukemia & Lymphoma. 1998-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: